Evidence map›Paper›PMID 41495345›Full record

ArticleBrain tumor pathology2026

Histologically indolent but widely disseminated diffuse midline glioma H3K27-altered revealed by autopsy.

Yosuke Kitagawa, Shota Tanaka, Hiroyuki Abe, Hirokazu Takami, Taijun Hana, Masashi Nomura, Shunsaku Takayanagi, Tetsuo Ushiku, Nobuhito Saito

Abstract read
PubMed Publisher
In one paragraph

Article in Brain tumor pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yosuke KitagawaDepartment of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shota TanakaDepartment of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikatacho, Kita-Ku, Okayama City, Okayama, 7008558, Japan. stanaka@okayama-u.ac.jp.
Hiroyuki AbeDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Hirokazu TakamiDepartment of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Taijun HanaDepartment of Neurosurgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Masashi NomuraDepartment of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shunsaku TakayanagiDepartment of Neuro-Oncology, International Medical Center, Saitama Medical University, Saitama, Japan.
Tetsuo UshikuDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Nobuhito SaitoDepartment of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Funding

Japan Society for the Promotion of Science 17K10857
6 · The paper itself

Abstract

Diffuse midline glioma, H3K27-altered is a highly aggressive central nervous system tumor classified as grade 4 in the 2021 World Health Organization Classification of Tumors of the Central Nervous System. This malignancy typically arises in midline structures such as the thalamus, brainstem, and spinal cord, and is characterized by its infiltrative capacity. Despite the use of magnetic resonance imaging to evaluate tumor extension, its microscopic dissemination can extend far beyond radiological detection. We report the case of a 46-year-old woman with a thalamic diffuse midline glioma harboring an H3K27M mutation. She underwent endoscopic resection followed by standard radiotherapy and chemotherapy with temozolomide. Despite salvage treatments, she died 33 months after initial therapy. Autopsy revealed widespread microscopic infiltration involving the brainstem, cerebellum, and spinal meninges, extending from the cervical to lumbar regions. Notably, these lesions were not detected by MRI or routine histopathology. This case highlights the extensive infiltrative capacity of diffuse midline glioma with H3K27M mutation, demonstrating its ability to permeate central nervous system structures while preserving tissue architecture.

Indexed as

AutopsyDiffuse midline gliomaH3F3AH3-K27MImmunohistochemistry

Identifiers

PMID41495345

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.